Pfizer Asks US Officials To OK Promising COVID-19 Pill





WASHINGTON — Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks.

The company’s antiviral is one of a handful of pills that have recently been shown to significantly cut hospitalizations and deaths among people infected with COVID-19.

If authorized by the Food and Drug Administration it could be a major step toward managing the pandemic, allowing patients to treat themselves at home.

FDA regulators will scrutinize company data on the safety and effectiveness of the drug, which will be sold as Paxlovid, before making a decision.





Source link

Leave a Reply

Your email address will not be published.

Related Post

1,000s Of Runners Return To The Streets Of Uptown For The Novant Health Charlotte Marathon On Saturday1,000s Of Runners Return To The Streets Of Uptown For The Novant Health Charlotte Marathon On Saturday



CHARLOTTE, N.C. — Event organizers say they are ready to safety welcome back thousands of runners for the 2021 Novant Health Charlotte Marathon on Saturday, after in-person events were cancelled